In the journal Cancer Cell, UNC Lineberger's Channing Der, PhD, and colleagues described how pancreatic cancer may develop resistance to ERK inhibitors in pancreatic cancer. November 16, 2018 Despite decades of research, treatments that can target a common mutation in the most frequently diagnosed type of pancreatic cancer have remained elusive. Now, University of North … Continue reading UNC Lineberger Writes: Researchers identify resistance mechanism to possible pancreatic cancer treatment
Kirsten Bryant authored a review in Cancer Cell, highlighting studies by Bar-Sagi and colleagues published in Cell.
Mutant RAS-driven cancers are infamously resistant to chemotherapeutics. Reporting in Cell, Grabocka and Bar-Sagi (2016) demonstrate that when subjected to stress, mutant KRAS-dependent lipid production leads to upregulated stress granule formation. This confers not only cell-autonomous cytoprotection but also paracrine establishment of a stress-resistant tumor niche. Mutant RAS Calms Stressed-Out Cancer Cells. Bryant KL, Der CJ. Dev Cell. … Continue reading Kirsten Bryant authored a review in Cancer Cell, highlighting studies by Bar-Sagi and colleagues published in Cell.
Der Lab 